Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies

被引：147

作者：

Shah, Nirav N. ^{[1
]}

Maatman, Theresa ^{[2
]}

Hari, Parameswaran ^{[1
]}

Johnson, Bryon ^{[1
]}

机构：

[1] Med Coll Wisconsin, Div Hematol & Oncol, Milwaukee, WI 53226 USA

[2] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA

来源：

FRONTIERS IN ONCOLOGY | 2019年 / 9卷

关键词：

CAR-T; antigen escape; B-cell NHL; B-cell ALL; immunotherapy; ANTIGEN ESCAPE; RECEPTOR; EFFICACY; RESISTANCE; LEUKEMIA;

D O I：

10.3389/fonc.2019.00146

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Chimeric antigen receptor (CAR) modified T cell therapy has revolutionized the treatment of relapsed and refractory hematological malignancies. Through targeting of the CD19 antigen on B cells durable remissions have been achieved in patients with B cell non-Hodgkin lymphoma and acute lymphoblastic lymphoma. Despite impressive responses, multiple escape mechanisms to evade CAR-T cell therapy have been identified, among which the most common is loss of the target antigen. In this review we will highlight outcomes to date with CD19 CAR-T cell therapy, describe the current limitations of single targeted CAR-T therapies, review identified tumor escape mechanisms, and lastly discuss novel strategies to overcome resistance via multi-targeted CAR-T cells.

引用

页数：7

共 50 条

[41] The Role of the Tumor Microenvironment in T-Cell Redirecting Therapies of Large B-Cell Lymphoma: Lessons Learned from CAR-T to Bispecific Antibodies [J].

Lepik, Kirill V. ;

Markelov, Vladislav V. .

CANCERS, 2025, 17 (02)

[42] Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignancies [J].

Temple, William C. ;

Nix, Matthew A. ;

Naik, Akul ;

Izgutdina, Adila ;

Huang, Benjamin J. ;

Wicaksono, Gianina ;

Phojanakong, Paul ;

Serrano, Juan Antonio Camara ;

Young, Elizabeth P. ;

Ramos, Emilio ;

Salangsang, Fernando ;

Steri, Veronica ;

Xirenayi, Simayijiang ;

Hermiston, Michelle ;

Logan, Aaron C. ;

Stieglitz, Elliot ;

Wiita, Arun P. .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (11)

[43] Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies [J].

Liu, Yangjie ;

Peng, Cao ;

Ahad, Faiza ;

Zaidi, Syed Aqib Ali ;

Muluh, Tobias Achu ;

Fu, Qiuxia .

RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2024, 19 (05) :557-572

[44] CAR-T cell therapy for patients with hematological malignancies. A systematic review [J].

Pasqui, Daniel M. ;

Latorraca, Carolina d O. C. ;

Pacheco, Rafael L. ;

Riera, Rachel .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 109 (06) :601-618

[45] CAR-T Cell Therapies From the Transfusion Medicine Perspective [J].

Fesnak, Andrew ;

Lin, ChieYu ;

Siegel, Don L. ;

Maus, Marcela V. .

TRANSFUSION MEDICINE REVIEWS, 2016, 30 (03) :139-145

[46] Exosomes in review: A new frontier in CAR-T cell therapies [J].

Wang, John S. ;

Schellenberg, Samuel J. ;

Demeros, Athena ;

Lin, Adam Y. .

NEOPLASIA, 2025, 62

[47] Relapse Mechanism and Treatment Strategy After Chimeric Antigen Receptor T-Cell Therapy in Treating B-Cell Hematological Malignancies [J].

Xie, Danni ;

Jin, Xin ;

Sun, Rui ;

Zhang, Meng ;

Wang, Jiaxi ;

Xiong, Xia ;

Zhang, Xiaomei ;

Zhao, Mingfeng .

TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 21

[48] CAR-T Cell Therapies: An Overview of Clinical Studies Supporting Their Approved Use against Acute Lymphoblastic Leukemia and Large B-Cell Lymphomas [J].

Ahmad, Aamir ;

Uddin, Shahab ;

Steinhoff, Martin .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (11) :1-9

[49] Novel CAR T cell therapies for patients with large B cell lymphoma [J].

Goto, Hideki ;

Onozawa, Masahiro ;

Teshima, Takanori .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (01) :6-14

[50] Identification of NOXA as a pivotal regulator of resistance to CAR T-cell therapy in B-cell malignancies [J].

Yan, Xin ;

Chen, Deyun ;

Wang, Yao ;

Guo, Yelei ;

Tong, Chuan ;

Wei, Jianshu ;

Zhang, Yajing ;

Wu, Zhiqiang ;

Han, Weidong .

SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)

← 1 2 3 4 5 →